Augmented BPTB autograft performs no better than standard autograft in ACL reconstruction .
Long-term results of a randomized study on anterior cruciate ligament reconstruction with or without a synthetic degradable augmentation device to support the autograft
Knee Surg Sports Traumatol Arthrosc. 2014 Sep;22(9):2109-20201 patients undergoing ACL reconstruction with a single-bundle bone-patellar tendon-bone autograft were randomized to either receive or not receive an augmentation device applied to the graft. The purpose was to compare clinical and functional outcome between the two techniques. Follow-up was conducted for 4 years postoperatively, and for 12 years in a subset of patients. The results demonstrated no significant difference between the augmented and nonaugmented graft with respect to knee laxity or clinical scores. By 4 years, 10 of the augmentation devices required removal.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
